Raia Drogasil S.A. (OTCMKTS:RADLY) Short Interest Update

Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totaling 1,032 shares, a drop of 95.3% from the April 15th total of 21,996 shares. Based on an average daily volume of 19,994 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Raia Drogasil Stock Down 2.7%

Shares of OTCMKTS RADLY traded down $0.12 during midday trading on Tuesday, reaching $4.25. 886 shares of the stock traded hands, compared to its average volume of 17,951. The company’s 50 day moving average is $4.59 and its 200 day moving average is $4.51. Raia Drogasil has a one year low of $2.17 and a one year high of $5.34.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

Get Our Latest Research Report on RADLY

Raia Drogasil Company Profile

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Featured Stories

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.